These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

657 related items for PubMed ID: 15943544

  • 1. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.
    Pelham WE, Burrows-Maclean L, Gnagy EM, Fabiano GA, Coles EK, Tresco KE, Chacko A, Wymbs BT, Wienke AL, Walker KS, Hoffman MT.
    Exp Clin Psychopharmacol; 2005 May; 13(2):111-26. PubMed ID: 15943544
    [Abstract] [Full Text] [Related]

  • 2. Methylphenidate and behavior modification in children with ADHD and comorbid ODD or CD: main and incremental effects across settings.
    Kolko DJ, Bukstein OG, Barron J.
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):578-86. PubMed ID: 10230190
    [Abstract] [Full Text] [Related]

  • 3. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ, Chou MC, Tzang RF, Hsu YC, Gau SS, Chen SJ, Wu YY, Huang YF, Liang HY, Cheng H.
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
    [Abstract] [Full Text] [Related]

  • 4. A dose-ranging study of a methylphenidate transdermal system in children with ADHD.
    Pelham WE, Manos MJ, Ezzell CE, Tresco KE, Gnagy EM, Hoffman MT, Onyango AN, Fabiano GA, Lopez-Williams A, Wymbs BT, Caserta D, Chronis AM, Burrows-Maclean L, Morse G.
    J Am Acad Child Adolesc Psychiatry; 2005 Jun; 44(6):522-9. PubMed ID: 15908834
    [Abstract] [Full Text] [Related]

  • 5. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ, Baird G, Pityaratstian N, Tavare E, Gringras P.
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
    Findling RL.
    Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
    [Abstract] [Full Text] [Related]

  • 8. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network.
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [Abstract] [Full Text] [Related]

  • 9. Effects of methylphenidate on aggressive urban children with attention deficit hyperactivity disorder.
    Bukstein OG, Kolko DJ.
    J Clin Child Psychol; 1998 Oct; 27(3):340-51. PubMed ID: 9789193
    [Abstract] [Full Text] [Related]

  • 10. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
    Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, Feldman HM, Pierce K, Wolraich ML, American Academy of Pediatrics Committee on Quality Improvement, American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder.
    Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
    [Abstract] [Full Text] [Related]

  • 11. Effects of MPH-OROS on the organizational, time management, and planning behaviors of children with ADHD.
    Abikoff H, Nissley-Tsiopinis J, Gallagher R, Zambenedetti M, Seyffert M, Boorady R, McCarthy J.
    J Am Acad Child Adolesc Psychiatry; 2009 Feb; 48(2):166-75. PubMed ID: 19127171
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sequential evaluation of behavioral treatments and methylphenidate dosage for children with attention deficit hyperactivity disorder.
    Gulley V, Northup J, Hupp S, Spera S, LeVelle J, Ridgway A.
    J Appl Behav Anal; 2003 Feb; 36(3):375-8. PubMed ID: 14596580
    [Abstract] [Full Text] [Related]

  • 15. Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate.
    Schachar RJ, Tannock R, Cunningham C, Corkum PV.
    J Am Acad Child Adolesc Psychiatry; 1997 Jun; 36(6):754-63. PubMed ID: 9183129
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD.
    McGough JJ, Wigal SB, Abikoff H, Turnbow JM, Posner K, Moon E.
    J Atten Disord; 2006 Feb; 9(3):476-85. PubMed ID: 16481664
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Developmental aspects of psychostimulant treatment in children and adolescents with attention-deficit/hyperactivity disorder.
    Findling RL, Short EJ, Manos MJ.
    J Am Acad Child Adolesc Psychiatry; 2001 Dec; 40(12):1441-7. PubMed ID: 11765290
    [Abstract] [Full Text] [Related]

  • 20. Effects of once-daily oral and transdermal methylphenidate on sleep behavior of children with ADHD.
    Faraone SV, Glatt SJ, Bukstein OG, Lopez FA, Arnold LE, Findling RL.
    J Atten Disord; 2009 Jan; 12(4):308-15. PubMed ID: 18400982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.